+1 (202) 780-3397
2023: Volume 8, Issue 3
Commentary P.1-2
Insights and perspectives of neurological disorders
Author(s): Drago Flaherty
DOI: 10.35841/aann-8.3.146
Opinion Article P.1-2
Neuromuscular manifestations of COVID-19 in children
Author(s): Marques Frank
DOI: 10.35841/aann-8.3.147
Perspective P.1-2
Pre-processing techniques for neurological disease detection
Author(s): Bailey Wagner
DOI: 10.35841/aann-8.3.148
Short Communication P.1-2
Neuropsychology: The complexities of the brain-mind connection
Author(s): Alonso Clancy
DOI: 10.35841/aann-8.3.149
Case Report P.1-2
The role of positron emission tomography in diagnosis and treatment
Author(s): Lewis Dussek
DOI: 10.35841/aann-8.3.150
Case Report P.1-2
Health technology assessment of gene therapies for neuromuscular diseases
Author(s): Lim Moore
DOI: 10.35841/aann-8.3.151
Rapid Communication P.1-2
Epigenetic alterations of brain tumor therapy
Author(s): Eyler Fontebasso
DOI: 10.35841/aann-8.3.152
Opinion Article P.1-2
Genetic and molecular pathogenesis of glioblastoma multiforme
Author(s): Brem Rourke
DOI: 10.35841/aann-8.3.153
Mini Review P.1-2
COVID-19 and muscular involvement in neuromuscular diseases
Author(s): Scouiller Knak
DOI: 10.35841/aann-8.3.154
Commentary P.1-2
The role of lineage-specific transcriptional regulators in neurological cancers
Author(s): Aldaz Garros
DOI: 10.35841/aann-8.3.155